BioRegenerative Sciences Releases Breakthrough Hair Regrowth Product for Women
July 2011
BioRegenerative Sciences, Inc., (BRS), a privately owned
stem cell therapeutics corporation headquartered in San Diego, CA,
USA, announced today the release of Hair Stemulating Complex for
Women (HSC), a unique, non-invasive and effective hair regrowth
formulation.
This breakthrough product will benefit the estimated
87 million people – in the US alone – who suffer from hair loss. BRS’
clinical trials in both women and men have shown significant hair
growth within 8 weeks following the daily application of the stem
cell-based formulation.
Dr. Greg Maguire, CEO of BioRegenerative Sciences, said “HSC is
formulated using BRS’s core technology where the molecules from
multiple stem cell types are used to mimic the natural healing and
growth processes of the human body.

HSC represents a scientific shift from conventional treatment options to one that promotes the growth of new or dormant hairs using the body's own naturally occurring regenerative mechanisms.
Estimates suggest that only 2-7% of the 87 million
hair loss sufferers in the United States seek surgical or
pharmacological treatment. Given the absence of effective medical
options for this widespread condition, the data may be projected on
a worldwide basis.
BRS’ laboratories have also developed an anti-aging cosmeceutical
product line based on the company’s proprietary and patented
technology: Vital Serum, Eye Serum and Moisturizing Night Cream,
scheduled to roll out later this month. The launch of Hair
Stemulating Complex for Men is planned for the 3rd Quarter 2011.
Hair Stemulating Complex is already available to consumers, and may
be purchased at www.bioregenerativesciences.com.
Source

.gif)

